Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase II Clinical Trial of Celecoxib in Persons with Genotype Positiv-261005126
University of Texas MD Anderson Cancer Center
Search grants from University of Texas MD Anderson Cancer Center
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Infrared Neuromodulation Reveals a New Understanding of Ganglion Organization
Inflammasomes and the mechanism of thymic demise in aging
Minnesota Environmental Public Health Tracking Network Implementation
Molecular Mechanisms of Intestinal Atrophy/Hyperplasia
Mechanisms of Retinoid Movement in the Eye
Recently added grants:
Converting staphylococcal pathogenicity islands from malevolence to benevolence
Structure-Guided Design of Broadly Neutralizing Lassa Virus BiSpecific Antibodies
Determination of the Interactome between Haemophilus ducreyi and the Human Host.
Mechanisms for Radiation Damage to DNA: LET Effects
Targeting Pancreatic Cancer Using Peptide Chemistry: From Bench to Bedside
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Prevention And Control (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CN005126-005
Application #
7329498
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2006
Total Cost
Indirect Cost
Institution
Name
University of Texas MD Anderson Cancer Center
Department
Type
DUNS #
City
State
Country
Zip Code
Related projects
NIH 2006
N01 CN
Phase II Clinical Trial of Celecoxib in Persons with Genotype Positiv-261005126
/ University of Texas MD Anderson Cancer Center
NIH 2005
N01 CN
Phase II Clinical Trial of Celecoxib in Persons with Genotype Positiv-261005126
/ University of Texas MD Anderson Cancer Center
NIH 2004
N01 CN
Phase II Clinical Trial of Celecoxib in Persons with Genotype Positiv-261005126
/ University of Texas MD Anderson Cancer Center
NIH 2000
N01 CN
Phase II Clinical Trial of Celecoxib in Persons with Ge
Lynch, Patrick M. / University of Texas MD Anderson Cancer Center
$3,251,125
Publications
Lynch, Patrick M; Ayers, Gregory D; Hawk, Ernie et al.
(2010)
The safety and efficacy of celecoxib in children with familial adenomatous polyposis.
Am J Gastroenterol 105:1437-43
Comments
Be the first to comment on this grant